Japan’s Daiichi Sankyo Expanding Pharmaceutical Business in U.S.

Japanese drug maker Daiichi Sankyo Co. Ltd. is expanding its U.S. pharmaceutical business in a bid to generate sales of at least 200 billion yen in the year to March 2010, double the sales figure for the year to March 2007, the Nikkei reported on Monday without citing sources.
Trading Markets